Pineal Gland Tetrapeptide — Ala-Glu-Asp-Gly
A synthetic tetrapeptide derived from Epithalamin — a natural extract of the bovine pineal gland. Epithalon has one of the longest research histories of any longevity peptide, with over 20 years of data from Professor Vladimir Khavinson's group in Russia. Its most striking property: activation of telomerase, the enzyme that extends telomeres and is directly linked to cellular lifespan.
01 — Research Summary
Epithalon holds a unique position in the peptide landscape: it has a longer continuous research history than virtually any other longevity-focused research peptide, driven primarily by Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology over more than two decades. While this research was conducted primarily in Russia and Eastern Europe under regulatory frameworks different from Western trials, the dataset is extensive and consistent.
The headline finding is telomerase activation. Telomeres — the protective caps on chromosomes — shorten with each cell division and are a primary driver of cellular aging. When telomeres reach a critical length, cells enter senescence or apoptosis. Epithalon has been shown to activate telomerase, the enzyme responsible for extending telomere length, both in cell culture and in animal models — and in limited human studies.
Beyond telomerase, Epithalon demonstrates consistent effects on pineal gland function — normalising melatonin secretion, restoring circadian rhythm, and modulating neuroendocrine function in aged subjects. These effects converge to produce a compound that addresses aging through multiple independent mechanisms simultaneously.
Telomere elongation in human cells. Cell culture studies confirmed Epithalon activates telomerase in human somatic cells (which normally lack telomerase activity), producing measurable telomere lengthening — directly demonstrating the mechanism linking it to cellular longevity.
Extended lifespan in multiple species. Multiple independent studies across mouse, rat, and Drosophila models have shown statistically significant lifespan extension with Epithalon — typically 20–30% in rodent models — alongside improved health span markers.
Melatonin restoration in elderly subjects. In elderly human subjects with age-related melatonin decline, Epithalon restored melatonin secretion patterns toward youthful norms, improving sleep architecture, circadian rhythm, and neuroendocrine function.
Reduced cancer incidence in long-term cohort. A 12-year follow-up study in elderly patients showed significantly reduced cancer incidence and all-cause mortality in subjects who received periodic Epithalon treatment versus controls — one of the most compelling human datasets for any longevity peptide.
Photoreceptor preservation in retinal degeneration. Epithalon demonstrated significant preservation of photoreceptor cells in retinitis pigmentosa models, suggesting protective effects in age-related retinal degeneration beyond its systemic anti-aging properties.
02 — Mechanism of Action
Epithalon's effects operate through several converging pathways, with telomerase activation as the most scientifically significant. Its pineal gland origin gives it a natural role as a neuroendocrine regulator — explaining its effects on melatonin, circadian rhythm, and systemic aging far beyond what a simple tetrapeptide might suggest.
Epithalon activates telomerase — the enzyme responsible for adding telomeric DNA repeats to the ends of chromosomes. In most somatic (body) cells, telomerase is silenced after development, leading to progressive telomere shortening with each division. Epithalon reactivates this enzyme, halting and potentially reversing this decline.
Epithalon stimulates the pineal gland to produce melatonin, which declines significantly with age. Restored melatonin production normalises circadian rhythms, improves sleep architecture, and activates melatonin's powerful antioxidant and anti-proliferative (anti-cancer) effects throughout the body.
By modulating the pineal-hypothalamic-pituitary axis, Epithalon exerts downstream effects on cortisol, GH, thyroid hormones, and sex hormones — effectively resetting the hormonal environment toward a younger physiological state. This is the likely mechanism behind its observed effects on energy, mood, and immune function.
Epithalon upregulates expression of antioxidant enzymes including superoxide dismutase (SOD) and catalase, reducing the chronic oxidative stress that accumulates with age and drives cellular damage, mitochondrial dysfunction, and inflammation.
Epithalon demonstrates immunomodulatory properties — enhancing T-cell function and natural killer (NK) cell activity while reducing pro-inflammatory cytokines. This may explain the reduced cancer incidence observed in long-term Epithalon cohorts, as immune surveillance of malignant cells is preserved.
Epithalon's 12-year human cohort data showing reduced cancer incidence is among the most compelling human evidence for any longevity-focused peptide. While the study was conducted in a Russian regulatory context and warrants replication, the consistency with mechanism (telomerase activation + immune enhancement) makes it scientifically plausible in a way few longevity compound claims are.
03 — Dosing Protocols
The following protocols are drawn from published research literature and established community practice. Individual responses vary significantly — always start at the lower end of any dose range and adjust based on personal response and professional guidance.
| Protocol | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Standard longevity cycle | 5–10 mg | Daily | 10–20 days | The Khavinson protocol: 10 days twice per year. SubQ or IM. |
| Extended cycle | 5 mg | Daily | 20 days | Some researchers run 20-day cycles for deeper effect. |
| Oral (lower bioavailability) | 10–20 mg | Daily | 20 days | Oral capsule — significantly lower bioavailability than injectable. |
| Anti-aging maintenance | 5 mg | Daily for 10 days | 2× per year | Original Khavinson protocol. Most referenced in literature. |
| Stacked — longevity | 5 mg Epithalon + 5 mg GHK-Cu | Daily | 10 days | Gene reset + telomere extension. Popular longevity combination. |
The Khavinson Protocol: The original clinical protocol used by Prof. Khavinson involves 10 consecutive daily injections, administered twice per year (spring and autumn). This remains the most referenced protocol and is the starting point most researchers use.
Oral vs injectable: Oral Epithalon has much lower bioavailability than injectable. Some researchers use significantly higher oral doses (20+ mg) to compensate. Injectable remains the gold standard for efficacy.
Epithalon is not FDA-approved for human use. All dosing information is from research literature and community protocols for educational purposes only. Consult a licensed healthcare professional before any protocol.
04 — Community Experiences
The following links surface real discussions from public research and wellness communities. These are anecdotal reports — not clinical evidence — and results vary significantly between individuals. We curate these as a transparency resource so you can read unfiltered user experiences alongside the science.
These are user-reported experiences from public forums. They are not endorsed by Whats That Peptide and should not be interpreted as clinical evidence of efficacy or safety. Individual results vary. Always consult a healthcare professional before starting any peptide protocol.
"I've done 4 cycles. Subjectively: sleep is dramatically better, energy is more consistent, and my skin looks noticeably different to people who knew me before I started. Bloodwork markers have all moved in positive directions."
"People dismiss it because it's Russian research. But Khavinson has 40+ years of peer-reviewed publications and the telomerase mechanism has been independently replicated. The cancer cohort data is genuinely compelling."
"My sleep architecture on my Oura ring completely changed during my first cycle. Slow-wave sleep increased by 22%. Whether it's melatonin or something deeper I don't know but the effect is real."
"Oral requires 3-4x the dose and you're guessing at absorption. If you're going to run Epithalon, do it properly with injectable. The 10-day cycle isn't that daunting and the difference in effect is significant."